ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2305

Infection Vulnerability in Pregnant Women with and Without Systemic Lupus Erythematosus

Dr Hiba Khogali1, Ghada Al‐Bluwi2, Virgie Guy2 and Ali Al Dhanhani3, 1Tawam Hospital, Al Ain, United Arab Emirates, 2College of Medicine, UAE University, Al Ain, United Arab Emirates, 3UAE University, Al Ain, United Arab Emirates

Meeting: ACR Convergence 2023

Keywords: Infection, pregnancy, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that predominantly affects women of childbearing age. Pregnant women with SLE have higher rates of adverse maternal and fetal outcomes than the general population. There is limited research on the risk of infection during pregnancy among women with SLE. This study aims to contribute to a better understanding of the incidence of infection in this population, the factors associated with increased infection risk, and compare the risk of infection among pregnant women with and without SLE.

Methods: Medical records from Tawam Hospital were reviewed retrospectively to identify patients with SLE (diagnosed based on ACR criteria) and pregnancy history. We collected data on demographics, clinical variables, and maternal (including infection). We randomly selected a one-to-one age-matched healthy control group and collected their pregnancy history. In cases of infection, we recorded the number and type of infection. We compared the infection odds ratios between pregnant women with and without SLE. Using multivariate analysis, we examined factors associated with infection in pregnant women with SLE.

Results: The outcomes of 78 pregnancies in 39 women with SLE and 107 pregnancies in 39 without SLE were analyzed. The mean age of both groups was similar (P=0.5). Infection episodes occurred in 55.8% of SLE pregnancies and 27% of non-SLE pregnancies (odds ratio 3.2, 95%CI 1.7-5.9). Among SLE pregnancies, we have a total of 98 infection episodes. In 51% of the SLE infections, patients received antibiotics. Most common infection was respiratory infection (43.9%), genitourinary (31.6%), skin and soft-tissue (9.2%), gastrointestinal (9.2%), and others (6.1%). In multivariate analysis, we examined demographic, SLE disease activity, and symptoms for association with increased risk of infection. We found no factors to increase the risk of infection among SLE pregnancies. However, hydroxychloroquine was protective against infection (table 1).

Table1. Multivariable analysis for factors associated with the risk of infection requiring antibiotics.

Variable

B

Odds ratio

P-value

Hydroxychloroquine during pregnancy

-1.73

.18

.05

Pulse steroids during pregnancy

1.32

3.73

.3

Conception at≥ 35 years

1.52

4.59

.09

Conclusion: Pregnant women with SLE have a significantly higher risk of infection compared to their non-SLE counterparts. The most common infection in SLE pregnancies was respiratory. No particular factors were identified to increase the infection risk among the SLE pregnancies. Interestingly, hydroxychloroquine use during pregnancy was found to be protective against infection. This finding highlights the importance of medication management in mitigating infection risks for pregnant women with SLE. However, further research is warranted to investigate the mechanisms involved in the increased risk of infection in pregnancies among women with SLE.


Disclosures: D. Khogali: None; G. Al‐Bluwi: None; V. Guy: None; A. Al Dhanhani: None.

To cite this abstract in AMA style:

Khogali D, Al‐Bluwi G, Guy V, Al Dhanhani A. Infection Vulnerability in Pregnant Women with and Without Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/infection-vulnerability-in-pregnant-women-with-and-without-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/infection-vulnerability-in-pregnant-women-with-and-without-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology